| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | amidine-lyase activity | 1.44e-04 | 7 | 53 | 2 | GO:0016842 | |
| GeneOntologyCellularComponent | gamma-secretase complex | 1.26e-04 | 7 | 52 | 2 | GO:0070765 | |
| GeneOntologyCellularComponent | somatodendritic compartment | 1.79e-04 | 1228 | 52 | 11 | GO:0036477 | |
| GeneOntologyCellularComponent | axon | 3.15e-04 | 891 | 52 | 9 | GO:0030424 | |
| GeneOntologyCellularComponent | actin-based cell projection | 6.26e-04 | 278 | 52 | 5 | GO:0098858 | |
| GeneOntologyCellularComponent | dendrite | 1.18e-03 | 858 | 52 | 8 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 1.20e-03 | 860 | 52 | 8 | GO:0097447 | |
| GeneOntologyCellularComponent | extrinsic component of postsynaptic membrane | 1.36e-03 | 22 | 52 | 2 | GO:0098890 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 2.29e-03 | 223 | 52 | 4 | GO:0098862 | |
| GeneOntologyCellularComponent | perikaryon | 2.29e-03 | 223 | 52 | 4 | GO:0043204 | |
| GeneOntologyCellularComponent | dendritic spine | 3.07e-03 | 242 | 52 | 4 | GO:0043197 | |
| GeneOntologyCellularComponent | synaptic membrane | 3.14e-03 | 583 | 52 | 6 | GO:0097060 | |
| GeneOntologyCellularComponent | growth cone | 3.21e-03 | 245 | 52 | 4 | GO:0030426 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 3.28e-03 | 405 | 52 | 5 | GO:0045211 | |
| GeneOntologyCellularComponent | neuron spine | 3.30e-03 | 247 | 52 | 4 | GO:0044309 | |
| GeneOntologyCellularComponent | extrinsic component of synaptic membrane | 3.43e-03 | 35 | 52 | 2 | GO:0099243 | |
| GeneOntologyCellularComponent | filopodium | 3.56e-03 | 123 | 52 | 3 | GO:0030175 | |
| GeneOntologyCellularComponent | site of polarized growth | 3.60e-03 | 253 | 52 | 4 | GO:0030427 | |
| GeneOntologyCellularComponent | neuronal cell body | 4.42e-03 | 835 | 52 | 7 | GO:0043025 | |
| GeneOntologyCellularComponent | distal axon | 4.44e-03 | 435 | 52 | 5 | GO:0150034 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | 4.56e-03 | 1307 | 52 | 9 | GO:0030659 | |
| GeneOntologyCellularComponent | vesicle membrane | 4.99e-03 | 1325 | 52 | 9 | GO:0012506 | |
| Domain | TPR_8 | 1.53e-05 | 53 | 53 | 4 | PF13181 | |
| Domain | RBD | 1.64e-04 | 7 | 53 | 2 | SM00455 | |
| Domain | RBD_dom | 1.64e-04 | 7 | 53 | 2 | IPR003116 | |
| Domain | RBD | 1.64e-04 | 7 | 53 | 2 | PS50898 | |
| Domain | SOLCAR | 4.57e-04 | 53 | 53 | 3 | PS50920 | |
| Domain | - | 4.57e-04 | 53 | 53 | 3 | 1.50.40.10 | |
| Domain | Mitochondrial_sb/sol_carrier | 4.57e-04 | 53 | 53 | 3 | IPR018108 | |
| Domain | Mito_carr | 4.57e-04 | 53 | 53 | 3 | PF00153 | |
| Domain | Mt_carrier_dom | 4.57e-04 | 53 | 53 | 3 | IPR023395 | |
| Domain | TPR | 4.89e-04 | 129 | 53 | 4 | SM00028 | |
| Domain | TPR_repeat | 5.49e-04 | 133 | 53 | 4 | IPR019734 | |
| Domain | NHL | 6.04e-04 | 13 | 53 | 2 | PS51125 | |
| Domain | DH_1 | 7.60e-04 | 63 | 53 | 3 | PS00741 | |
| Domain | TPR-contain_dom | 8.62e-04 | 150 | 53 | 4 | IPR013026 | |
| Domain | RhoGEF | 9.49e-04 | 68 | 53 | 3 | SM00325 | |
| Domain | RhoGEF | 1.03e-03 | 70 | 53 | 3 | PF00621 | |
| Domain | DH_2 | 1.03e-03 | 70 | 53 | 3 | PS50010 | |
| Domain | DH-domain | 1.08e-03 | 71 | 53 | 3 | IPR000219 | |
| Domain | - | 1.08e-03 | 71 | 53 | 3 | 1.20.900.10 | |
| Domain | TPR_REGION | 1.23e-03 | 165 | 53 | 4 | PS50293 | |
| Domain | TPR | 1.23e-03 | 165 | 53 | 4 | PS50005 | |
| Domain | PH_dom-like | 1.26e-03 | 426 | 53 | 6 | IPR011993 | |
| Domain | - | 2.81e-03 | 207 | 53 | 4 | 1.25.40.10 | |
| Domain | Aden_trnslctor | 2.85e-03 | 28 | 53 | 2 | IPR002113 | |
| Domain | Kringle-like | 3.71e-03 | 32 | 53 | 2 | IPR013806 | |
| Domain | Mit_carrier | 3.71e-03 | 32 | 53 | 2 | IPR002067 | |
| Domain | TPR-like_helical_dom | 4.28e-03 | 233 | 53 | 4 | IPR011990 | |
| Domain | - | 4.93e-03 | 391 | 53 | 5 | 2.30.29.30 | |
| Domain | ANF_lig-bd_rcpt | 4.94e-03 | 37 | 53 | 2 | IPR001828 | |
| Domain | ANF_receptor | 4.94e-03 | 37 | 53 | 2 | PF01094 | |
| Domain | Myosin_head_motor_dom | 5.20e-03 | 38 | 53 | 2 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 5.20e-03 | 38 | 53 | 2 | PS51456 | |
| Domain | Myosin_head | 5.20e-03 | 38 | 53 | 2 | PF00063 | |
| Domain | MYSc | 5.20e-03 | 38 | 53 | 2 | SM00242 | |
| Domain | GDS_CDC24_CS | 5.47e-03 | 39 | 53 | 2 | IPR001331 | |
| Domain | Peripla_BP_I | 5.47e-03 | 39 | 53 | 2 | IPR028082 | |
| Domain | - | 5.47e-03 | 39 | 53 | 2 | 2.120.10.30 | |
| Domain | PDZ | 7.49e-03 | 141 | 53 | 3 | PF00595 | |
| Domain | FERM_M | 7.55e-03 | 46 | 53 | 2 | PF00373 | |
| Domain | 6-blade_b-propeller_TolB-like | 7.55e-03 | 46 | 53 | 2 | IPR011042 | |
| Domain | PH | 7.94e-03 | 278 | 53 | 4 | SM00233 | |
| Domain | PH_DOMAIN | 8.04e-03 | 279 | 53 | 4 | PS50003 | |
| Domain | PH_domain | 8.14e-03 | 280 | 53 | 4 | IPR001849 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | 1.50e-05 | 702 | 39 | 10 | M746 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | 5.19e-05 | 646 | 39 | 9 | MM14962 | |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | 5.56e-05 | 76 | 39 | 4 | M19832 | |
| Pathway | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | 1.44e-04 | 97 | 39 | 4 | M9400 | |
| Pathway | REACTOME_NONCANONICAL_ACTIVATION_OF_NOTCH3 | 1.55e-04 | 7 | 39 | 2 | MM15612 | |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 1.98e-04 | 197 | 39 | 5 | M12289 | |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 1.98e-04 | 197 | 39 | 5 | MM14970 | |
| Pathway | REACTOME_NONCANONICAL_ACTIVATION_OF_NOTCH3 | 2.07e-04 | 8 | 39 | 2 | M27887 | |
| Pathway | KEGG_REGULATION_OF_ACTIN_CYTOSKELETON | 2.85e-04 | 213 | 39 | 5 | M18306 | |
| Pathway | PID_ANGIOPOIETIN_RECEPTOR_PATHWAY | 3.30e-04 | 49 | 39 | 3 | M92 | |
| Pathway | REACTOME_TGFBR3_PTM_REGULATION | 3.31e-04 | 10 | 39 | 2 | MM17232 | |
| Pathway | REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR | 3.31e-04 | 10 | 39 | 2 | MM14744 | |
| Pathway | REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS | 3.72e-04 | 51 | 39 | 3 | M27311 | |
| Pathway | REACTOME_NOTCH4_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 4.04e-04 | 11 | 39 | 2 | M27882 | |
| Pathway | REACTOME_TGFBR3_PTM_REGULATION | 4.04e-04 | 11 | 39 | 2 | M48251 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 4.04e-04 | 11 | 39 | 2 | M47865 | |
| Pathway | REACTOME_NUCLEAR_SIGNALING_BY_ERBB4 | 4.04e-04 | 11 | 39 | 2 | MM14534 | |
| Pathway | REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR | 4.04e-04 | 11 | 39 | 2 | M2661 | |
| Pathway | REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS | 6.65e-04 | 14 | 39 | 2 | MM14826 | |
| Pathway | REACTOME_DEATH_RECEPTOR_SIGNALING | 8.37e-04 | 154 | 39 | 4 | M27697 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 8.68e-04 | 272 | 39 | 5 | M13380 | |
| Pathway | REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS | 8.73e-04 | 16 | 39 | 2 | M7257 | |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | 9.43e-04 | 70 | 39 | 3 | MM14824 | |
| Pathway | PID_SYNDECAN_3_PATHWAY | 9.88e-04 | 17 | 39 | 2 | M251 | |
| Pathway | KEGG_RENIN_ANGIOTENSIN_SYSTEM | 9.88e-04 | 17 | 39 | 2 | M17636 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 1.08e-03 | 430 | 39 | 6 | MM15160 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 1.24e-03 | 19 | 39 | 2 | MM15594 | |
| Pathway | REACTOME_SIGNALING_BY_TGFBR3 | 1.52e-03 | 21 | 39 | 2 | MM17231 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 1.58e-03 | 463 | 39 | 6 | M507 | |
| Pathway | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | 1.65e-03 | 85 | 39 | 3 | MM14746 | |
| Pathway | REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 1.66e-03 | 22 | 39 | 2 | M27210 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 2.04e-03 | 330 | 39 | 5 | M18334 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 2.07e-03 | 92 | 39 | 3 | M27201 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 2.13e-03 | 333 | 39 | 5 | MM14963 | |
| Pathway | REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 2.15e-03 | 25 | 39 | 2 | M27879 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 2.62e-03 | 210 | 39 | 4 | MM15043 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 2.95e-03 | 217 | 39 | 4 | M18437 | |
| Pubmed | 1.16e-07 | 7 | 53 | 3 | 33983932 | ||
| Pubmed | Ten years on: mediation of cell death by the common neurotrophin receptor p75(NTR). | 2.20e-06 | 60 | 53 | 4 | 12787561 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 22589727 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 33454014 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 36259376 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 36446235 | ||
| Pubmed | Identification and validation of Ifit1 as an important innate immune bottleneck. | 2.28e-06 | 2 | 53 | 2 | 22745654 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 23824812 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 27823966 | ||
| Pubmed | A viral RNA structural element alters host recognition of nonself RNA. | 2.28e-06 | 2 | 53 | 2 | 24482115 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 11707441 | ||
| Pubmed | Sequestration by IFIT1 impairs translation of 2'O-unmethylated capped RNA. | 2.28e-06 | 2 | 53 | 2 | 24098121 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 27240734 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 14550769 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 25927359 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 30282041 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 26157117 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 26459629 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 18997336 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | MEST SLC25A12 SUPT5H RPF2 MRPS23 SMARCA4 TSPYL5 MYO1B TNXB ZBED5 | 4.71e-06 | 1082 | 53 | 10 | 38697112 |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 7896268 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 12110170 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 30232164 | ||
| Pubmed | Mouse p56 blocks a distinct function of eukaryotic initiation factor 3 in translation initiation. | 6.83e-06 | 3 | 53 | 2 | 15561726 | |
| Pubmed | Novel characteristics of the function and induction of murine p56 family proteins. | 6.83e-06 | 3 | 53 | 2 | 18768971 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 35034537 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 19856081 | ||
| Pubmed | Identification of a serotonin/glutamate receptor complex implicated in psychosis. | 6.83e-06 | 3 | 53 | 2 | 18297054 | |
| Pubmed | Association between 3'UTR polymorphisms in genes ACVR2A, AGTR1 and RGS2 and preeclampsia. | 6.83e-06 | 3 | 53 | 2 | 29593124 | |
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 16371134 | ||
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 24991014 | ||
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 24198415 | ||
| Pubmed | The in vivo roles of STEF/Tiam1, Rac1 and JNK in cortical neuronal migration. | 1.36e-05 | 4 | 53 | 2 | 12912917 | |
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 24478444 | ||
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 17079283 | ||
| Pubmed | Interferon-induced Ifit proteins: their role in viral pathogenesis. | 1.36e-05 | 4 | 53 | 2 | 25428874 | |
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 16582578 | ||
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 8660659 | ||
| Pubmed | Tissue-specific and inducer-specific differential induction of ISG56 and ISG54 in mice. | 1.36e-05 | 4 | 53 | 2 | 17553874 | |
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 15619115 | ||
| Pubmed | Sendai virus pathogenesis in mice is prevented by Ifit2 and exacerbated by interferon. | 1.36e-05 | 4 | 53 | 2 | 25231314 | |
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 37496288 | ||
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 16733060 | ||
| Pubmed | The PHCCEx domain of Tiam1/2 is a novel protein- and membrane-binding module. | 1.36e-05 | 4 | 53 | 2 | 19893486 | |
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 19477188 | ||
| Pubmed | 2.27e-05 | 5 | 53 | 2 | 29879406 | ||
| Pubmed | 2.27e-05 | 5 | 53 | 2 | 27137933 | ||
| Pubmed | A small modulatory dsRNA specifies the fate of adult neural stem cells. | 2.27e-05 | 5 | 53 | 2 | 15035981 | |
| Pubmed | Gamma-secretase is a membrane protein complex comprised of presenilin, nicastrin, Aph-1, and Pen-2. | 2.27e-05 | 5 | 53 | 2 | 12740439 | |
| Pubmed | Ifit2 Is a Restriction Factor in Rabies Virus Pathogenicity. | 2.27e-05 | 5 | 53 | 2 | 28637751 | |
| Pubmed | Interferon-induced Ifit2/ISG54 protects mice from lethal VSV neuropathogenesis. | 2.27e-05 | 5 | 53 | 2 | 22615570 | |
| Pubmed | Control of cardiac jelly dynamics by NOTCH1 and NRG1 defines the building plan for trabeculation. | 2.71e-05 | 38 | 53 | 3 | 29743679 | |
| Pubmed | Endocardial Brg1 represses ADAMTS1 to maintain the microenvironment for myocardial morphogenesis. | 2.71e-05 | 38 | 53 | 3 | 18267097 | |
| Pubmed | 3.40e-05 | 6 | 53 | 2 | 15474363 | ||
| Pubmed | 3.40e-05 | 6 | 53 | 2 | 14717705 | ||
| Pubmed | APH1, PEN2, and Nicastrin increase Abeta levels and gamma-secretase activity. | 3.40e-05 | 6 | 53 | 2 | 12763021 | |
| Pubmed | 3.40e-05 | 6 | 53 | 2 | 32277054 | ||
| Pubmed | The broad-spectrum antiviral functions of IFIT and IFITM proteins. | 3.40e-05 | 6 | 53 | 2 | 23237964 | |
| Pubmed | Cloning and chromosomal location of human genes inducible by type I interferon. | 3.40e-05 | 6 | 53 | 2 | 3175763 | |
| Pubmed | Transcriptional landscape of pulmonary lymphatic endothelial cells during fetal gestation. | 4.76e-05 | 7 | 53 | 2 | 31083674 | |
| Pubmed | 2'-O methylation of the viral mRNA cap evades host restriction by IFIT family members. | 4.76e-05 | 7 | 53 | 2 | 21085181 | |
| Pubmed | 6.34e-05 | 8 | 53 | 2 | 10206645 | ||
| Pubmed | Preimplantation mouse embryo is a target for opioid ligand-receptor signaling. | 6.34e-05 | 8 | 53 | 2 | 24855103 | |
| Pubmed | Purification and characterization of the human gamma-secretase complex. | 6.34e-05 | 8 | 53 | 2 | 15274632 | |
| Pubmed | 6.97e-05 | 916 | 53 | 8 | 32203420 | ||
| Pubmed | The mitochondrial transporter family SLC25: identification, properties and physiopathology. | 7.42e-05 | 53 | 53 | 3 | 23266187 | |
| Pubmed | Prosaposin facilitates sortilin-independent lysosomal trafficking of progranulin. | 8.05e-05 | 149 | 53 | 4 | 26370502 | |
| Pubmed | Irf8-regulated genomic responses drive pathological inflammation during cerebral malaria. | 8.15e-05 | 9 | 53 | 2 | 23853600 | |
| Pubmed | 8.15e-05 | 9 | 53 | 2 | 11359462 | ||
| Pubmed | An essential role for Cmtr2 in mammalian embryonic development. | 8.15e-05 | 9 | 53 | 2 | 39094818 | |
| Pubmed | 8.15e-05 | 9 | 53 | 2 | 30380406 | ||
| Pubmed | 9.44e-05 | 300 | 53 | 5 | 19086053 | ||
| Pubmed | 9.86e-05 | 963 | 53 | 8 | 28671696 | ||
| Pubmed | Antiviral Protection via RdRP-Mediated Stable Activation of Innate Immunity. | 1.02e-04 | 10 | 53 | 2 | 26633895 | |
| Pubmed | ARID1a-DNA interactions are required for promoter occupancy by SWI/SNF. | 1.02e-04 | 10 | 53 | 2 | 23129809 | |
| Pubmed | 1.02e-04 | 10 | 53 | 2 | 12091320 | ||
| Pubmed | 1.02e-04 | 10 | 53 | 2 | 12843241 | ||
| Pubmed | A protein-RNA interaction atlas of the ribosome biogenesis factor AATF. | 1.11e-04 | 162 | 53 | 4 | 31363146 | |
| Pubmed | Targeting HIV transcription: the quest for a functional cure. | 1.24e-04 | 11 | 53 | 2 | 25731772 | |
| Pubmed | 1.24e-04 | 11 | 53 | 2 | 17986144 | ||
| Pubmed | Genetic risk factors in typical haemolytic uraemic syndrome. | 1.49e-04 | 12 | 53 | 2 | 19110485 | |
| Pubmed | 1.49e-04 | 12 | 53 | 2 | 28874170 | ||
| Pubmed | 1.49e-04 | 12 | 53 | 2 | 11891216 | ||
| Pubmed | 1.49e-04 | 12 | 53 | 2 | 12074840 | ||
| Pubmed | Association study of 182 candidate genes in anorexia nervosa. | 1.74e-04 | 182 | 53 | 4 | 20468064 | |
| Pubmed | Postnatal gene expression in the normal mouse cornea by SAGE. | 2.05e-04 | 14 | 53 | 2 | 14744882 | |
| Pubmed | 2.05e-04 | 14 | 53 | 2 | 7622488 | ||
| Pubmed | 2.05e-04 | 14 | 53 | 2 | 16630834 | ||
| Pubmed | Tlx1 and Tlx3 coordinate specification of dorsal horn pain-modulatory peptidergic neurons. | 2.36e-04 | 15 | 53 | 2 | 18400903 | |
| Pubmed | 2.36e-04 | 15 | 53 | 2 | 11341749 | ||
| Pubmed | Host-cell sensors for Plasmodium activate innate immunity against liver-stage infection. | 2.36e-04 | 15 | 53 | 2 | 24362933 | |
| Pubmed | 2.36e-04 | 15 | 53 | 2 | 27917469 | ||
| Pubmed | 2.36e-04 | 15 | 53 | 2 | 19166692 | ||
| Pubmed | 2.62e-04 | 81 | 53 | 3 | 22723691 | ||
| Pubmed | 2.70e-04 | 16 | 53 | 2 | 20161734 | ||
| Pubmed | 2.70e-04 | 16 | 53 | 2 | 15721744 | ||
| Pubmed | 3.24e-04 | 87 | 53 | 3 | 17979178 | ||
| Pubmed | PTENα and PTENβ promote carcinogenesis through WDR5 and H3K4 trimethylation. | 3.40e-04 | 217 | 53 | 4 | 31685992 | |
| Pubmed | 3.43e-04 | 18 | 53 | 2 | 27001747 | ||
| Pubmed | A conserved acetylation switch enables pharmacological control of tubby-like protein stability. | 3.77e-04 | 223 | 53 | 4 | 33187986 | |
| Cytoband | 1q21-q23 | 1.01e-04 | 13 | 53 | 2 | 1q21-q23 | |
| Cytoband | 10q23.31 | 7.16e-04 | 34 | 53 | 2 | 10q23.31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q23 | 1.51e-03 | 195 | 53 | 3 | chr10q23 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 1.19e-04 | 115 | 40 | 4 | 769 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.09e-03 | 206 | 40 | 4 | 682 | |
| GeneFamily | Endogenous ligands | 1.82e-03 | 237 | 40 | 4 | 542 | |
| GeneFamily | PDZ domain containing | 4.58e-03 | 152 | 40 | 3 | 1220 | |
| GeneFamily | Fibronectin type III domain containing | 5.29e-03 | 160 | 40 | 3 | 555 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 5.47e-03 | 50 | 40 | 2 | 1293 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 9.36e-03 | 66 | 40 | 2 | 722 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | TANC2 SGIP1 CLCA1 GTF3C2 ATF7IP GRIA2 MYO1B NOL10 MME TENM2 TIAM2 | 6.48e-06 | 850 | 53 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.27e-05 | 478 | 53 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.09e-07 | 192 | 53 | 6 | dc40ef2341e5d6a6d479f140e023fe1bf687928d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.12e-07 | 193 | 53 | 6 | c7e9e6e4bf5e07c9cbdf1aa7c8828f4b2500e3ff | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.50e-07 | 146 | 53 | 5 | ec1f793409d1a81c0f9323eb3c82ffe01dae0e44 | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|tumor_Lung / Location, Cell class and cell subclass | 2.58e-06 | 183 | 53 | 5 | a03dd563af9b15cb1f5de5732a229405a9f82d84 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.65e-06 | 184 | 53 | 5 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | COPD-Stromal-Pericyte|COPD / Disease state, Lineage and Cell class | 2.65e-06 | 184 | 53 | 5 | a56264a22dfc2d3672b20134ab7c3c7c23da5ae1 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.65e-06 | 184 | 53 | 5 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.72e-06 | 185 | 53 | 5 | a7dba7db79275884b2a93d8a16f2e0c739e71370 | |
| ToppCell | COVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations) | 2.72e-06 | 185 | 53 | 5 | 4905adaeeffd353e089578e5ea614437dbe794e6 | |
| ToppCell | COPD-Stromal-Pericyte|World / Disease state, Lineage and Cell class | 2.80e-06 | 186 | 53 | 5 | 8adfd2d1fda4e8aecc95192ea627bf7ed5214b8d | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-06 | 186 | 53 | 5 | 4bb54043f944a979db91bde9a86dd66f498c7658 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.80e-06 | 186 | 53 | 5 | 6379609b7ace80683f5754b16aa77f11b43766ae | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.18e-06 | 191 | 53 | 5 | de54dab85db70f847de75b3b6d7667a0e13b9bfb | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.43e-06 | 194 | 53 | 5 | 8f19e553f18c313c2a2ff9453884b9484b255d71 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.43e-06 | 194 | 53 | 5 | 67fbb81b7d20cb63be27b2a2beea5b5689f8e08c | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.43e-06 | 194 | 53 | 5 | f95935153bd2c4c3c7b2b729da6f7e98b45fed79 | |
| ToppCell | IPF-Stromal-Pericyte|World / Disease state, Lineage and Cell class | 3.43e-06 | 194 | 53 | 5 | 1a41da29d5adaf766a84eff0003b959e4523f7f1 | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|lung / Disease (COVID-19 only), tissue and cell type | 3.43e-06 | 194 | 53 | 5 | 5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3 | |
| ToppCell | IPF-Stromal-Pericyte|IPF / Disease state, Lineage and Cell class | 3.61e-06 | 196 | 53 | 5 | 8b6ff47ce5291d223f5e639fc45cd9267f418256 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-Pericytes-Pericyte|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.70e-06 | 197 | 53 | 5 | 452be45f4aac8459dd860493171f5f715368d663 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Pericyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.98e-06 | 200 | 53 | 5 | d70bad979299615fcba707ba21296020918705e6 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.98e-06 | 200 | 53 | 5 | 8158f4eaeff945a6788c8e732b7a1b0d78052a06 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Smooth_Muscle_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 3.98e-06 | 200 | 53 | 5 | 55ac281901309e30978da1f7489386e54489721e | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.98e-06 | 200 | 53 | 5 | 38c21ec379005f688df33aea65237a063c476c2e | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Pericyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.98e-06 | 200 | 53 | 5 | 600d56257b1b0cda8ed2fd0db92c6551711f7d6d | |
| ToppCell | Parenchymal-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.98e-06 | 200 | 53 | 5 | f9bc22ff17bb1c751e6b05bca3f403836f33459a | |
| ToppCell | Parenchymal-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.98e-06 | 200 | 53 | 5 | 0a7640db28c708003d5da2d19eb651f6fedfd710 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Fibcd1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.75e-05 | 130 | 53 | 4 | c70fb77324916d220d842a575558a8245c276599 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.61e-05 | 144 | 53 | 4 | e2a2f260f5ebaaef46248d199c407a15ce9d024a | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Cbln4_Fezf2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.94e-05 | 160 | 53 | 4 | d8241404d775f9a709abdf17988f36293fcf4c58 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-05 | 161 | 53 | 4 | f1d3287d9cb4e0eec99b3509f5dc4b87ae8c8cc9 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-05 | 161 | 53 | 4 | 110cc7122e3c9f105a11d811d77c8a8852b9de6c | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.34e-05 | 164 | 53 | 4 | 4cfc9f92e49f86d3639e018b35b6a60dc62f494a | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.34e-05 | 164 | 53 | 4 | 7a8e5ef52a8fd2877d59ef0696af8a7af90bbed6 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.34e-05 | 164 | 53 | 4 | 5e5bd81414ea2d64f73cdef19a0a78c17bec8c18 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.34e-05 | 164 | 53 | 4 | f13b8d9b7f42193f333d9a77571a1dde6bbb48d8 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.76e-05 | 168 | 53 | 4 | 8072d0496b7b730c4601009eaa69ec5366d26d73 | |
| ToppCell | Control-Stromal-Pericyte|World / Disease state, Lineage and Cell class | 5.22e-05 | 172 | 53 | 4 | 813d4256b05b66ca11b08cc0026459d79f12c0eb | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D231|Adult / Lineage, Cell type, age group and donor | 5.22e-05 | 172 | 53 | 4 | 858cee96c1c06160863b4adcd7023c0d678bd50f | |
| ToppCell | Control-Stromal-Pericyte|Control / Disease state, Lineage and Cell class | 5.46e-05 | 174 | 53 | 4 | 91fc1f1c891f105a91968c22e2de5321c52b439a | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.71e-05 | 176 | 53 | 4 | 05ec715439f2eb1696f5d8855da0dd1dd70effd0 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.83e-05 | 177 | 53 | 4 | 452ec2df36c6d656a7cdadc55be545ccdb146a29 | |
| ToppCell | cellseq2-Mesenchymal-Myocytic-Myocytic_1-Pericyte|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.83e-05 | 177 | 53 | 4 | 68263456a3c93cd195b321b309ff59e156d732fe | |
| ToppCell | cellseq2-Mesenchymal-Myocytic-Myocytic_1|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.83e-05 | 177 | 53 | 4 | e415e448c37adc102d766235e9953dec32c021f1 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.96e-05 | 178 | 53 | 4 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.96e-05 | 178 | 53 | 4 | 51d2188406f04329311b2efd1108fc36617a860e | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.09e-05 | 179 | 53 | 4 | 7c8a2fa1326c73dc9e774df645b572864fd97133 | |
| ToppCell | droplet-Bladder-nan-24m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.09e-05 | 179 | 53 | 4 | dfd9d29281510d32f1a2e8336d2e58ef496cfd1d | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.09e-05 | 179 | 53 | 4 | dc6cd46fa652b296ddbc41855f6377946d0a4cdc | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.23e-05 | 180 | 53 | 4 | cfc8bfbfd3617aabbb49f9730c29b673ca157e74 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.23e-05 | 180 | 53 | 4 | 8bf6e8b6b45ce42f8c5f23e7cd1752ec8b3fa2d2 | |
| ToppCell | normal_Lung-Fibroblasts-Pericytes|normal_Lung / Location, Cell class and cell subclass | 6.36e-05 | 181 | 53 | 4 | f74941e49950027360d71ea3b205fc20c6929766 | |
| ToppCell | Control-Myeloid-Alveolar_macrophages|Control / group, cell type (main and fine annotations) | 6.36e-05 | 181 | 53 | 4 | 8d2102c8c86c59a82610f26f90946b290552e666 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.36e-05 | 181 | 53 | 4 | 166ff44fcc0a2943b7f485ea8a9c314964e013bb | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L2-4_RORB_GRIK1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.36e-05 | 181 | 53 | 4 | 57994ff4ecffb15653aee00644d9f887f5e3461d | |
| ToppCell | COVID-19-kidney-CD-IC-B|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.50e-05 | 182 | 53 | 4 | ee6a8c356bbbdae55e4ea858337e079491f9f4aa | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.64e-05 | 183 | 53 | 4 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.78e-05 | 184 | 53 | 4 | 4a9f798c67b9998bffe44242b210cc1e224ff5b1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.92e-05 | 185 | 53 | 4 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.92e-05 | 185 | 53 | 4 | 9197f074e769d54031ec41abfc65fcc0c6552c7e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.92e-05 | 185 | 53 | 4 | ce7d62394b09c26ca65b8cdb280afec5e25bbb62 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.92e-05 | 185 | 53 | 4 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.07e-05 | 186 | 53 | 4 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.07e-05 | 186 | 53 | 4 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | COPD-Stromal-Pericyte|Stromal / Disease state, Lineage and Cell class | 7.22e-05 | 187 | 53 | 4 | 406ecd1dabb3ed8d871aef159f7bd1e383434953 | |
| ToppCell | COVID-19-kidney-CD-IC-B|kidney / Disease (COVID-19 only), tissue and cell type | 7.22e-05 | 187 | 53 | 4 | ce05b89860573fe0356102e2998d1ef6d1968034 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.37e-05 | 188 | 53 | 4 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 7.52e-05 | 189 | 53 | 4 | c05b4b565c0ce56dbb45fc9503654a2ec1a7e1e9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.52e-05 | 189 | 53 | 4 | 99a13b1b669b0cd36e3096632351d9ade25d1173 | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 7.52e-05 | 189 | 53 | 4 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | IPF-Myeloid-Macrophage_Alveolar|IPF / Disease state, Lineage and Cell class | 7.68e-05 | 190 | 53 | 4 | e539ebc0f4c5ee5dba86c614387be7d91338ad47 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.68e-05 | 190 | 53 | 4 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.68e-05 | 190 | 53 | 4 | f50b9814a1beac67dc042a8c27dfd085ceeda3a6 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.68e-05 | 190 | 53 | 4 | a22a510b4a257eb0eaf09c7ae7978d3d2f07a58c | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.68e-05 | 190 | 53 | 4 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.68e-05 | 190 | 53 | 4 | 1bbbf0ce222e51f9fd2daca0c18d3965fd4efd31 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.68e-05 | 190 | 53 | 4 | 57c136bf6d7feafb4a220877bed0cc8fdf314db2 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Immature_INs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 7.68e-05 | 190 | 53 | 4 | 842760bfe0a52e67bad800efa7d99448a4a23ebb | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.83e-05 | 191 | 53 | 4 | fd01a206763dfb6d52cca67123571936b4a8e1a0 | |
| ToppCell | PSB-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.83e-05 | 191 | 53 | 4 | 8f4637e801554e2343b974fe7794f01dd2151418 | |
| ToppCell | Control-Myeloid|Control / group, cell type (main and fine annotations) | 7.83e-05 | 191 | 53 | 4 | 9c4acc5f3c2f9c0c5520863bb22f391774372347 | |
| ToppCell | ILEUM-non-inflamed-(6)_ILC3|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.83e-05 | 191 | 53 | 4 | 6eaf72b41084404bee0db04e4605db745a74995f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.83e-05 | 191 | 53 | 4 | 1626b23a57429f835fddc052e3c57f63a4e5b8bb | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.83e-05 | 191 | 53 | 4 | 54f07e4de61735051498846afb44b1798bed8144 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.83e-05 | 191 | 53 | 4 | 716dfa7fccbd62b5f574792e68a26dc6c45511dc | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.83e-05 | 191 | 53 | 4 | 7b0d42a877540dbb346a76a62403e0d5d3e07fa6 | |
| ToppCell | COVID-19-lung-Macrophage_PPARGhi_CD5Lhi|lung / Disease (COVID-19 only), tissue and cell type | 7.83e-05 | 191 | 53 | 4 | dab953682b8c9ed680a799161f837f792a7e4f33 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.83e-05 | 191 | 53 | 4 | 657297cd19d05a7e7bb74fc3a086fbd95f47aae4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.83e-05 | 191 | 53 | 4 | cd854b9c426924fdc84bf7f411f6dea447143e79 | |
| ToppCell | droplet-Pancreas-Endocrine-18m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.99e-05 | 192 | 53 | 4 | 4510aa262da8dcf7c944b3907a51aba5a9397a4e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.15e-05 | 193 | 53 | 4 | 010717ca052b6c8a525a43aaeffddea0d1113e63 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.15e-05 | 193 | 53 | 4 | b2abe939027a69b60d83a28d4d4cc53ba1dee4c5 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.15e-05 | 193 | 53 | 4 | 87ce81ff5b27d9c4300826d76ff5a62e9c408d5d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.15e-05 | 193 | 53 | 4 | 2189da4b727e25e62669d7b9257f06493be21a27 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.15e-05 | 193 | 53 | 4 | d75f334fe3d9f39ef02a5de0f8202f7a761a8fc8 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.15e-05 | 193 | 53 | 4 | 2483bb7f398e4fa0ef09c8bd584ed25703853f03 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.15e-05 | 193 | 53 | 4 | 53bcd50892c379b2a571751f6eb1062436339fe7 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.15e-05 | 193 | 53 | 4 | 41ea268e7697101fe70d8ef1045f3a43b9311739 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.15e-05 | 193 | 53 | 4 | 5581a5ebcd21a2a8062ccfb917f088ec67a10a9c | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.32e-05 | 194 | 53 | 4 | 415801a3dfacf05f2b603fb424df3d045190a812 | |
| Computational | Adrenal gland - metabolic genes. | 9.83e-05 | 314 | 38 | 7 | MODULE_19 | |
| Drug | Propioxatin A | 5.32e-06 | 2 | 53 | 2 | CID000128218 | |
| Drug | Phelorphan | 5.32e-06 | 2 | 53 | 2 | CID000187071 | |
| Drug | Ici 154129 | 6.53e-06 | 16 | 53 | 3 | CID003035055 | |
| Drug | boroleucine | 1.59e-05 | 3 | 53 | 2 | CID000127495 | |
| Drug | carbaphethiol | 1.59e-05 | 3 | 53 | 2 | CID003037579 | |
| Drug | 125I]iodo- | 1.78e-05 | 22 | 53 | 3 | CID000644290 | |
| Drug | Rges Peptide | 2.04e-05 | 23 | 53 | 3 | CID000121927 | |
| Drug | Deltakephalin | 2.33e-05 | 24 | 53 | 3 | CID000119319 | |
| Drug | prochloraz | 3.02e-05 | 155 | 53 | 5 | CID000073665 | |
| Drug | phethiol | 3.18e-05 | 4 | 53 | 2 | CID000136802 | |
| Drug | KPLP | 3.18e-05 | 4 | 53 | 2 | CID000133544 | |
| Drug | Cocaine | MRC1 SUPT5H CYP26A1 PENK GRIA2 FEV MME GRM2 TENM2 RGS2 FRMD5 TIAM2 | 3.81e-05 | 1314 | 53 | 12 | ctd:D003042 |
| Drug | Kelatorphan | 4.63e-05 | 30 | 53 | 3 | CID000123982 | |
| Drug | Tyr-gly-gly-phe | 4.63e-05 | 30 | 53 | 3 | CID006453937 | |
| Drug | Daeam | 5.29e-05 | 5 | 53 | 2 | CID009570639 | |
| Drug | Pencina | 5.29e-05 | 5 | 53 | 2 | CID000030729 | |
| Drug | GW8510; Down 200; 10uM; PC3; HT_HG-U133A | 6.50e-05 | 182 | 53 | 5 | 7085_DN | |
| Drug | EIPA | 7.12e-05 | 95 | 53 | 4 | CID000001795 | |
| Drug | DSLET | 7.40e-05 | 35 | 53 | 3 | CID000107847 | |
| Drug | haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 9.22e-05 | 196 | 53 | 5 | 1041_UP | |
| Drug | Propafenone hydrochloride [34183-22-7]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 9.22e-05 | 196 | 53 | 5 | 2871_UP | |
| Drug | C070379 | 9.90e-05 | 199 | 53 | 5 | CID003034747 | |
| Drug | BAPTA | 1.04e-04 | 324 | 53 | 6 | CID000104751 | |
| Drug | Morphiceptin | 1.11e-04 | 40 | 53 | 3 | CID000119303 | |
| Drug | chromanone | 1.11e-04 | 7 | 53 | 2 | CID000068110 | |
| Drug | RB 38A | 1.11e-04 | 7 | 53 | 2 | CID000129130 | |
| Drug | alpiropride | 1.11e-04 | 7 | 53 | 2 | CID000071253 | |
| Drug | AC1L1KMJ | 1.12e-04 | 476 | 53 | 7 | CID000030956 | |
| Drug | L000369 | 1.19e-04 | 41 | 53 | 3 | CID003931705 | |
| Drug | AC1NNRU4 | 1.19e-04 | 41 | 53 | 3 | CID005126051 | |
| Drug | AC1L1I54 | 1.19e-04 | 41 | 53 | 3 | CID000004426 | |
| Drug | AC1L1KS5 | 1.22e-04 | 334 | 53 | 6 | CID000005631 | |
| Drug | 2,4-TDI | 1.28e-04 | 42 | 53 | 3 | CID000011443 | |
| Drug | HCBP-Gly | 1.48e-04 | 8 | 53 | 2 | CID000124786 | |
| Drug | Dithionite | 1.48e-04 | 8 | 53 | 2 | ctd:D004227 | |
| Drug | cFP-F-pAB | 1.48e-04 | 8 | 53 | 2 | CID000132283 | |
| Drug | Saapna | 1.48e-04 | 8 | 53 | 2 | CID005748178 | |
| Drug | aminopeptidase N inhibitor | 1.48e-04 | 8 | 53 | 2 | CID010067728 | |
| Drug | Epiamastatin hydrochloride | 1.49e-04 | 115 | 53 | 4 | CID000003237 | |
| Drug | AC1L63MU | 1.51e-04 | 347 | 53 | 6 | CID000285703 | |
| Drug | blebbistatin | 1.54e-04 | 116 | 53 | 4 | CID003476986 | |
| Drug | Gly-D-Phe | 1.68e-04 | 46 | 53 | 3 | CID000092953 | |
| Drug | ibotenic acid | 1.88e-04 | 122 | 53 | 4 | CID000001233 | |
| Drug | aspartate | 1.89e-04 | 518 | 53 | 7 | CID000000424 | |
| Drug | CHEMBL1783187 | 1.89e-04 | 9 | 53 | 2 | CID005230731 | |
| Drug | AC1MJ5M1 | 1.89e-04 | 9 | 53 | 2 | CID003086119 | |
| Drug | N-carboxymethyl-Phe-Leu | 1.89e-04 | 9 | 53 | 2 | CID000004356 | |
| Drug | beta-Neurokinin | 2.03e-04 | 49 | 53 | 3 | CID000055583 | |
| Drug | AC1L1GTT | 2.07e-04 | 233 | 53 | 5 | CID000003837 | |
| Drug | NSC265489 | 2.19e-04 | 127 | 53 | 4 | CID000003238 | |
| Drug | SB10 | 2.36e-04 | 10 | 53 | 2 | CID000046019 | |
| Drug | NSC351912 | 2.36e-04 | 10 | 53 | 2 | CID000100168 | |
| Drug | CAS 87333-19-5 | 2.57e-04 | 53 | 53 | 3 | CID000005038 | |
| Drug | PDBu | 2.81e-04 | 249 | 53 | 5 | CID000037783 | |
| Drug | Trimu-5 | 2.89e-04 | 11 | 53 | 2 | CID005487273 | |
| Drug | Cfp-aaf-pab | 2.89e-04 | 11 | 53 | 2 | CID005748203 | |
| Drug | Rb 104 | 2.89e-04 | 11 | 53 | 2 | CID000132708 | |
| Drug | N-acetylcystine | 2.89e-04 | 11 | 53 | 2 | CID000065352 | |
| Disease | cataract 48 (implicated_via_orthology) | 2.93e-06 | 2 | 51 | 2 | DOID:0070354 (implicated_via_orthology) | |
| Disease | heroin dependence (implicated_via_orthology) | 1.75e-05 | 4 | 51 | 2 | DOID:9976 (implicated_via_orthology) | |
| Disease | brain disease (implicated_via_orthology) | 4.37e-05 | 6 | 51 | 2 | DOID:936 (implicated_via_orthology) | |
| Disease | Tourette syndrome | 9.00e-05 | 50 | 51 | 3 | EFO_0004895 | |
| Disease | glomerulosclerosis (biomarker_via_orthology) | 1.31e-04 | 10 | 51 | 2 | DOID:0050851 (biomarker_via_orthology) | |
| Disease | Alzheimer disease | 1.84e-04 | 485 | 51 | 6 | MONDO_0004975 | |
| Disease | adenosine monophosphate measurement | 4.40e-04 | 18 | 51 | 2 | EFO_0010454 | |
| Disease | coronary artery disease (is_implicated_in) | 6.99e-04 | 100 | 51 | 3 | DOID:3393 (is_implicated_in) | |
| Disease | serum gamma-glutamyl transferase measurement | 9.44e-04 | 914 | 51 | 7 | EFO_0004532 | |
| Disease | Drug habituation | 1.05e-03 | 115 | 51 | 3 | C0013170 | |
| Disease | Substance-Related Disorders | 1.05e-03 | 115 | 51 | 3 | C0236969 | |
| Disease | Drug abuse | 1.05e-03 | 115 | 51 | 3 | C0013146 | |
| Disease | Drug Use Disorders | 1.05e-03 | 115 | 51 | 3 | C0013222 | |
| Disease | Drug Dependence | 1.05e-03 | 115 | 51 | 3 | C1510472 | |
| Disease | Substance Dependence | 1.05e-03 | 115 | 51 | 3 | C0038580 | |
| Disease | Substance Use Disorders | 1.05e-03 | 115 | 51 | 3 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.05e-03 | 115 | 51 | 3 | C0029231 | |
| Disease | Prescription Drug Abuse | 1.05e-03 | 115 | 51 | 3 | C4316881 | |
| Disease | Substance abuse problem | 1.07e-03 | 116 | 51 | 3 | C0740858 | |
| Disease | sensorineural hearing loss (is_implicated_in) | 1.49e-03 | 33 | 51 | 2 | DOID:10003 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FRFAYYKLLKKASEG | 86 | Q8WW43 | |
| NKKGFRIRYIAFYCS | 2556 | Q7Z407 | |
| ALIFAGFGFYLYKQR | 3641 | Q7Z407 | |
| FYGFLGKKFKRYFLQ | 301 | P30556 | |
| KVHGKRYAYRFDFQG | 116 | Q99581 | |
| FTYLRAGSGRYRYQK | 456 | Q14416 | |
| FFASRKGYSRKGFDR | 926 | P19021 | |
| KTIYAKEGGFFGFYR | 176 | P16260 | |
| YQKRYGGFLKRFAEA | 226 | P01210 | |
| FYSKRYSRALYLGAK | 316 | Q9UJX3 | |
| AVREAAYKRFGYKLA | 601 | Q9UKN7 | |
| KYLLKFVSDYGRNGF | 2166 | Q9UKN7 | |
| FYRNGDRYFKGLVFA | 76 | Q8N568 | |
| YVAGNFPFYKRSKAG | 131 | Q6ZQN5 | |
| FSRGVYAIFGFYDKK | 81 | P42262 | |
| TYKESRNAFRKALYG | 386 | P08473 | |
| GFYYKTRIPKFGRDF | 126 | Q9BSC4 | |
| KLNLCRKYYLGGFAF | 11 | Q9NZ42 | |
| GYSRKKGGFSFRFGR | 121 | P83859 | |
| YKLGFFKRSLPYGTA | 1021 | P08648 | |
| FFKGSRFRYSGRVAK | 311 | Q7Z6J6 | |
| SKQSGSFRKFRYGYN | 686 | O75173 | |
| KKRLLGTFFRVAFYG | 1756 | Q5JSL3 | |
| YAAKFYRRKGSVDKA | 256 | Q5T764 | |
| GSKYYFAVRAKDIYG | 1236 | Q6VMQ6 | |
| SGKKYGFSLRAIRVY | 956 | O60307 | |
| TYVFRYAAKFYRRKG | 251 | P09914 | |
| YAAKFYRRKGSVDKA | 256 | P09914 | |
| GFFYGKKRNRTLYAS | 941 | P14616 | |
| KRRKYGFIYKTHLFG | 71 | O43174 | |
| SGKFFTYKGLRIFYQ | 46 | Q5EB52 | |
| GKYGFKRFLRDGYRT | 326 | Q93100 | |
| TGAGLAAYFFYKKRR | 1401 | P22897 | |
| RAKFYSVYGSGQRAF | 71 | Q9Y3D9 | |
| KYGLAAFRAFLKSEF | 91 | P41220 | |
| ILYGFLSYRFKQGFR | 311 | P32745 | |
| AYRLRDGHFKYAFGS | 196 | Q96BN2 | |
| FAYRGFKYLRLDGTT | 1116 | P51532 | |
| RYQYALKKFPREGFG | 1266 | Q9HCD6 | |
| FLGTGRQVFYKYGKL | 2011 | Q9NT68 | |
| FEGNRYSRKGFLFKS | 361 | O00267 | |
| FLKTYAQVGLRGFYK | 51 | Q9BXI2 | |
| FTALNGKIYFRSYKL | 186 | Q9H7B2 | |
| KAYLDFREKGGYRTT | 76 | Q8WUX2 | |
| FKKVLRYEGFFGLYR | 376 | O75746 | |
| SLYLLEATGKRFYFK | 61 | A8K7I4 | |
| FKKVLFSLGGSFLYY | 1121 | Q13009 | |
| FSLGGSFLYYADRFK | 1126 | Q13009 | |
| RKLLFSLGGSFLYYA | 1181 | Q8IVF5 | |
| VGAGYRFSLIKKRFA | 806 | Q9BQI5 | |
| YKFVLYGFVGKKRHG | 1126 | P22105 | |
| KRRKYDESYLSFGFT | 106 | Q49AG3 | |
| RDGKYGFYTHVFRLK | 596 | P00734 | |
| VKITSFRGYDFYGLK | 251 | Q6ZR37 | |
| AGYLGFKAYFTAPRK | 691 | Q8WUA4 | |
| GLARLGYKIKFYFDR | 286 | Q86VY4 | |
| EYRKFFRANAGKKIY | 856 | O43795 |